Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia

Cardiotoxicity is a well-known pathophysiological consequence in breast cancer patients receiving trastuzumab. Trastuzumab related cardiotoxicity typically results in an overall decline in cardiac function, primarily characterized by reduction in left ventricular ejection fraction (LVEF) and develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Pillai, Sneha S., Pereira, Duane G., Bonsu, Gloria, Chaudhry, Hibba, Puri, Nitin, Lakhani, Hari Vishal, Tirona, Maria Tria, Sodhi, Komal, Thompson, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411945/
https://www.ncbi.nlm.nih.gov/pubmed/36034829
http://dx.doi.org/10.3389/fphar.2022.953178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411945/
https://www.ncbi.nlm.nih.gov/pubmed/36034829
http://dx.doi.org/10.3389/fphar.2022.953178

Ejemplares similares